Clinics running high patient volumes on transvaginal, transrectal, or surface ultrasound often ask a version of the same question: do we really need high-level disinfection (HLD) between every patient if we are already using a probe cover? The question is understandable — HLD adds time, equipment cost, and staffing complexity to every scan. The answer, according to the CDC’s Spaulding classification system for medical devices, is unambiguous: these procedures involve semi-critical devices, and probe covers and HLD are not interchangeable. They are complementary, and skipping either one changes the cost-benefit calculation significantly.
Why Probe Covers Alone Are Not Sufficient
The clinical literature on this point is blunt. Sterile transvaginal probe covers have been found, in published studies, to have failure rates before use as high as 65% from some suppliers, and used-cover perforation rates as high as 75–81% after procedures such as oocyte retrieval. Even the better-performing products in these studies still showed measurable leakage. This is why CDC infection-control guidance requires a new probe cover for every patient and treats HLD of the probe itself as non-negotiable — not as a backup step, but as the control that actually eliminates the risk a compromised probe cover leaves behind.
The Real Cost of High-Level Disinfection
- Capital cost of an automated HLD cabinet or a UV-C / chemical wipe system.
- Consumables — chemical wipes, or reagents such as ortho-phthalaldehyde, replaced on an ongoing schedule.
- Staff time per cycle, which reduces patient throughput in a busy clinic or early-pregnancy assessment service.
- Compliance risk — one multicentre study found that only around 2% of scanning episodes followed every recommended step (probe disinfection, keyboard protection, and hand hygiene) in full, which means the theoretical cost of HLD and the actual protective benefit delivered in practice can diverge sharply without proper protocol enforcement.
The Real Cost of Probe Covers
Per-unit cost is low compared to HLD equipment, which is exactly why some clinics are tempted to treat covers as the whole solution. But the studies above show that probe cover quality varies enormously between suppliers, and a cheap, high-perforation probe cover provides only the appearance of protection.
Weighing the Cost of Getting It Wrong
The financial comparison only looks complete once the cost of a failure is on the same page as the cost of prevention. A single documented healthcare-associated infection traced to inadequate probe hygiene carries costs far beyond the disinfection budget: clinical treatment, regulatory scrutiny, potential litigation, and reputational damage that can outlast any of it. Against that backdrop, the incremental cost of a reliable, low-perforation probe cover combined with consistent HLD is a small price for the risk it removes.
Building a Cost-Effective Protocol
The most defensible protocol — clinically and financially — pairs a single-use, low-failure-rate probe cover with full HLD between every patient, backed by staff training that closes the compliance gap identified in the studies above. Neither element substitutes for the other. For a deeper look at day-to-day practice, see our clinical guide to best practices for ultrasound hygiene and preventing HAIs.
Where Nulatex Fits
Nulatex manufactures ISO 13485-certified, medical-grade probe covers as part of the same rigorous quality system covered in our article on electronic pin-hole testing and quality assurance, and supply healthcare facilities and distributors as part of our broader global health manufacturing programme.
